28/02/2022

EuropaBio Statement on Rare Disease Day

13/12/2021

Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.
27/05/2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

25/05/2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
20/05/2021

Decentralised clinical trials, the future of clinical research

The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
29/04/2021

EuropaBio on NGT study: A positive step towards delivering innovation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
31/03/2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
24/09/2020

Genome editing FAQ

Genome editing is an advance in biological tools with the potential for a wide range of applications.
24/08/2020

Genome-Edited Products and Projects: Resources and Examples

This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
30/06/2020

EuropaBio observations in response to Europe’s Beating Cancer Plan

EuropaBio welcomes the European Commission’s commitment to develop a European plan to fight cancer and is supportive of its overarching approach in tackling all key stages of the disease: prevention, early diagnosis, treatment, and quality of life. Above all, we strongly advocate the employment of supportive measures for health innovation to ensure that novel cancer treatments move from the laboratory to the hospital bedside as swiftly as possible.
20/05/2020

The impact of COVID-19 on patients with chronic or life-threatening conditions

Read our latest blog on the impact of the pandemic on patients with chronic diseases and rare conditions around the globe.
20/05/2020

EuropaBio position on Germline Genome Editing

EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet. In medicine, genome editing offers the prospect of saving lives and tackling some of the most devastating genetic diseases.
30/04/2020

How soon can we respond to COVID-19?

The development of a vaccine or an antiviral treatment is a long and complex process. So why are we hearing that a vaccine against COVID-19 may be ready in a year from now, or even sooner?
30/04/2020

CRISPR and Coronavirus

A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.
30/04/2020

Clinical Trials and Coronavirus

Check out the latest news on coronavirus clinical trials.
30/03/2020

Biotechnology spearheads the fight against COVID-19

Learn how biotechnology can contribute towards fighting COVID-19 in our latest blog post.
29/02/2020

Strike Rare Diseases at the Root!

Read our newest blog on the occasion of Rare Disease Day on the 29th of February.
26/01/2020

What if we could definitively cure AIDS

A combination of antiviral therapy and genome editing has succeeded in removing the HIV virus from infected mice.
25/01/2020

Create immunotherapy treatments for cancer

Immunotherapy has a long history of use against cancer: in the 1890’s bacteria was injected into a tumour in an attempt to encourage a response by the immune system against the cancer.
15/01/2020

Create ‘living drugs’ that treat cancer

Treatment for certain cancers has taken a huge leap forward thanks to new “living drugs”, created through biotechnology.
Become a member